Mission Statement
|
| "Converting breakthrough discoveries into life-altering drugs " |
From Discovery to Patients
From Discovery to Patients
A public-private partnership to translate science into products
Eclosion was created in 2004 in Geneva as a platform to translate inventions in the field of life sciences into economic value and jobs. Eclosion offers a platform where scientists can access the know-how, operational resources and funding required to perform a first proof-of-concept (POC) of their discovery. Once POC is established, Eclosion helps incorporate, structure and staff a start-up to pursue the development of the application, facilitating access to seed capital and subsequent financial rounds all the way to clinical trials.
Eclosion is set-up as an “open innovation platform”, integrating the strengths of the State, Academia, Industry and Investors to create the best possible development environment to make a project succeed. Alone, infrastructure, equipment, knowledge or capital cannot ensure success. It is the combination of all these elements within the Eclosion management process that has ensured the success of the companies launched through Eclosion.
From Proof of Concept to clinical trials
Each life-science project requires its own extremely specific set of scientific skills and specialized infrastructures to select, validate and successfully launch a product development. As an example, a discovery in molecular biology may provide a potential new therapeutic target; yet validating this target and defining the right product development strategy require many contributions, including for example experienced clinicians with hands-on research expertise in the target indication; bioinformatics specialists, medicinal chemists; pharmacologists, intellectual property, regulatory experts, etc,
Eclosion accesses the specific know-how and infrastructures that are needed to validate and launch successful projects. While it has facilities in Geneva to provide a physical hub for researchers, it success comes from its network to access knowledge, and its process to perform step by step hands-on validation of projects.
Eclosion was founded in 2004, and in 8 years it has created some of the most promising start-ups in the biotech field. Companies such as GeNeuro or GenKyoTex, which were breakthrough scientific concepts in 2004, made their POC with Eclosion, have developed their drugs with and are now into clinical trials.
Working with Eclosion
Eclosion is open to all scientists working in the field of human medicine that have great science and want to test its potential applications. No business plan needed, just scientific excellence and the potential to develop breakthrough applications that change the life of patients.
The Eclosion team will work with you to define the POC that may demonstrate this potential, assemble the resources required to perform it, and help you create a well structured and funded company to develop it.